معرفی
Clemens Wittenbecher is an Assistant Professor at the Department of Food and Nutrition Science at Chalmers University of Technology. His research focuses on applying novel omics approaches to predict cardiometabolic risk and understand how diet composition influences future disease risk. He works with large observational cohorts including the Harvard cohorts, EPIC study, PREDIMED trial, and Swedish SCAPIS and SIMPLER cohorts.
Dr. Wittenbecher's research centers on metabolomic profiling and its links with dietary patterns and disease risk. He has effectively utilized methodologies in causal modeling and metabolic network analysis to explore the complexities of nutritional epidemiology. His work has revealed specific metabolic signatures that respond to dietary components, contributing to our understanding of how these components modulate cardiometabolic risk. His research spans precision nutrition, cardiometabolic diseases, and biomarker discovery.
His recent publications demonstrate a strong focus on precision nutrition approaches for cardiometabolic diseases, with particular emphasis on lipidomics and metabolomics. The research spans from biomarker discovery to dietary interventions across diverse populations, with consistent application of advanced statistical methods to large cohort data. His work bridges nutritional science with clinical outcomes, particularly in diabetes, cardiovascular disease, and metabolic syndrome.
- Wallenberg data-driven life science fellowship
- VR starting grant in health and medicine
Dr. Wittenbecher has profound experience in leading and supervising precision nutrition research projects and is centrally involved in major US and Scandinavian precision nutrition research networks. He initiated the Precision Nutrition Forum in Gothenburg, which attracts seminal nutrition and multi-omics researchers from the US and Europe. His work involves extensive collaboration across international research teams working with large-scale cohort data.
His research is conducted within the context of major international collaborative networks focused on precision nutrition. He works closely with researchers from Harvard, European institutions involved in the EPIC study, and Scandinavian research groups. His work leverages data from multiple large-scale cohorts to identify metabolic signatures that respond to dietary components and influence disease risk.
